TD Cowen raised the firm’s price target on AvePoint (AVPT) to $21 from $20 and keeps a Buy rating on the shares. AvePoint continues to see durable demand trends driven by strength in spending around GenAI and Security initiatives, says the analyst, who expects “a continued beat & raise cadence.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AVPT:
- AvePoint’s Strong Performance and Promising Outlook: Buy Rating Affirmed by Jason Ader
- AvePoint Reports Strong Q1 2025 Financial Growth
- AvePoint sees Q2 revenue $95.3M-$97.3M, consensus $92.04M
- AvePoint raises FY25 revenue view to $397.4M-$405.4M from $380M-$388M
- AvePoint reports Q1 EPS 2c, consensus 5c